Discussion on the biologic therapy of inflammatory bowel disease

被引：1
|
作者：
Merger, M [1 ]
Herfarth, H
Scholmerich, J
Andus, T
Färber, L
机构：
[1] Klinikum Univ Regensburg, Klin & Poliklin Innere Med 1, Regensburg, Germany
[2] Novartis, Nurnberg, Germany
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 07期
关键词：
D O I：
10.1016/S0016-5085(03)00578-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2005 / 2006
页数：2
相关论文
共 50 条
  • [41] Biologic Therapy Response Improves Sexual Dysfunction in Patients With Inflammatory Bowel Disease
    Castillo, Gabriel
    Beaty, William
    Ahsan, Maaz
    Miller, Jennifer
    Sultan, Keith
    Friedman, Sonia
    Lukin, Dana
    Axelrad, Jordan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S608 - S608
  • [42] HISTOPLASMOSIS IN THE SETTING OF BIOLOGIC THERAPY: A TERTIARY CARE INFLAMMATORY BOWEL DISEASE EXPERIENCE
    Sarker, Shabnam
    Law, Michelle E.
    Horst, Sara N.
    Nohl, Anne J.
    Duley, Caroline
    Annis, Kim
    Wiese, Dawn M.
    Schwartz, David A.
    Beaulieu, Dawn
    GASTROENTEROLOGY, 2017, 152 (05) : S579 - S579
  • [43] Changes in gut microbiota of patients with inflammatory bowel disease receiving biologic therapy
    Tai, W. C.
    Yao, C. C.
    Tsai, Y. -C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2153 - I2153
  • [44] Efficacy and effectiveness of biologic therapy in inflammatory bowel disease. EFIFECT study
    Ginard, Daniel
    Khorrami, Sam
    Perez-Carazo, Leticia
    Tavio-Hernandez, Eduardo
    Lopez-Sanroman, Antonio
    Garcia-Alvarado, Maria
    Munoz, Fernando
    Ibanez-Samaniego, Luis
    Marin-Jimenez, Ignacio
    Guevara, Jorge
    Casellas, Francesc
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (06): : 369 - 376
  • [45] Biologic and Immunomodulator Therapy Improves Depressive Symptoms in Subjects With Inflammatory Bowel Disease
    Horst, Sara N.
    Gaines, Lawrence S.
    Rosen, Michael J.
    Duley, Caroline
    Wagnon, Julianne H.
    Walker, Lynn S.
    Beaulieu, Dawn B.
    Schwartz, David A.
    GASTROENTEROLOGY, 2011, 140 (05) : S588 - S588
  • [46] Gut Microbial Changes in Inflammatory Bowel Disease Patients in Response to Biologic Therapy
    Yilmaz, Bahtiyar
    Juillerat, Pascal
    Bravo, Francisco D.
    Wiest, Reiner
    Macpherson, Andrew
    SWISS MEDICAL WEEKLY, 2017, 147 : 12S - 12S
  • [47] VACCINATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY, ARE THEY BEING CONSIDERED?
    Chatten, K.
    Cornthwaite, L.
    Nixon, E.
    Goel, A.
    GUT, 2017, 66 : A243 - A244
  • [48] Dual Biologic Therapy for the Treatment of Pediatric Inflammatory Bowel Disease: A Review of the Literature
    Wlazlo, Magdalena
    Kierkus, Jaroslaw
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [49] LOWER SUSTAINED PERTUSSIS CONCENTRATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGIC THERAPY
    Caldera, Freddy
    McCrone, Sue
    Garmoe, Christine A.
    Megna, Bryant W.
    Ley, Dana
    Reichelderfer, Mark
    Hayney, Mary S.
    GASTROENTEROLOGY, 2017, 152 (05) : S59 - S59
  • [50] 10 Year Performance of Anti TNF Biologic Therapy in Inflammatory Bowel Disease
    Perera, Lilani P.
    Zadvornova, Yelena
    Binion, David G.
    Guilday, Corinne
    Stein, Daniel J.
    Naik, Amar S.
    Venu, Nanda
    Best, Kari
    Skaros, Susan
    GASTROENTEROLOGY, 2012, 142 (05) : S351 - S351
12345